Evrofarma SA (ATH:EVROF)
3.970
+0.100 (2.58%)
May 29, 2026, 5:10 PM EET
95.57% (1Y)
| Market Cap | 54.27M +110.0% |
| Revenue (ttm) | 49.44M +8.1% |
| Net Income | 3.53M +54.6% |
| EPS | 0.26 +54.7% |
| Shares Out | 13.67M |
| PE Ratio | 15.39 |
| Forward PE | n/a |
| Dividend | 0.06 (1.51%) |
| Ex-Dividend Date | Aug 19, 2026 |
| Volume | 5,345 |
| Open | 3.910 |
| Previous Close | 3.870 |
| Day's Range | 3.860 - 3.990 |
| 52-Week Range | 1.920 - 4.070 |
| Beta | 0.73 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 25, 2026 |